Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery

Osteoporosis International

Volumn 27, Issue 5, 2016, Pages 1719-1727

  Drew, S ^a   Judge, A ^a,b   Cooper, C ^a,b   Javaid, M K ^a,b   Farmer, A ^a   Gooberman Hill, R ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Epidemiology; Fracture; Fragility; Hip; Osteoporosis; Qualitative

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; PARATHYROID HORMONE[1-34]; STRONTIUM RANELATE; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

AGE; ARTICLE; CASE FINDING; COMPUTER PROGRAM; CONSENSUS; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; FRACTURE PREVENTION; FRACTURE TREATMENT; FRAGILITY FRACTURE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HIP FRACTURE; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; NURSE; OSTEOPOROSIS; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; QUALITATIVE RESEARCH; RHEUMATOLOGY; SECONDARY FRACTURE; SECONDARY HEALTH CARE; SECONDARY PREVENTION; SEMI STRUCTURED INTERVIEW; TRAUMA SURGEON; WORKLOAD; AGED; ENGLAND; HEALTH PERSONNEL ATTITUDE; HIP FRACTURES; INTEGRATED HEALTH CARE SYSTEM; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; OSTEOPOROTIC FRACTURES; PHOTON ABSORPTIOMETRY; PROCEDURES; RECURRENT DISEASE;

ABSORPTIOMETRY, PHOTON; AGE FACTORS; AGED; ATTITUDE OF HEALTH PERSONNEL; BONE DENSITY CONSERVATION AGENTS; DELIVERY OF HEALTH CARE, INTEGRATED; ENGLAND; HIP FRACTURES; HUMANS; MODELS, ORGANIZATIONAL; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; QUALITATIVE RESEARCH; RECURRENCE; SECONDARY PREVENTION;

EID: 84954321962     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-015-3452-z     Document Type: Article

References (32)

1. British Orthopaedic Association (2007) The care of patients with fragility fractures
2. Dennison E, Mohamed MA, Cooper C (2006) Epidemiology of osteoporosis. Rheum Dis Clin N Am 32(4):617–629
3. Chesser TJS, Handley R, Swift C (2011) New NICE guideline to improve outcomes for hip fracture patients. Injury 42(8):727–729
4. Johnell O et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15(3):175–179
5. Abrahamsen B et al (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20(10):1633–1650
6. Knopp J et al (2005) Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int 16(10):1281–1290
7. Black DM et al (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res 14(5):821–828
8. NICE (2008) Technology appraisal (TA) 161. Osteoporosis—secondary prevention including strontium ranelate
9. Scottish Intercollegiate Guidelines Network (2009) Management of hip fracture in older patients. A National Clinical Guideline 111
10. NICE (2004) Clinical guideline 21. Clinical practice guideline for the assessment and prevention of falls in older people
11. Akesson K et al (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24(8):2135–2152
12. Marsh D et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22(7):2051–2065
13. Drew S et al (2014) Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England. Osteoporos Int
14. Sumner M (2006) Qualitative research. The SAGE Dictionary of Social Research Methods. SAGE Publications, Ltd. London, England: SAGE Publications, Ltd. 249–251
15. Ayres L (2008) The SAGE encyclopedia of qualitative research methods. SAGE publications, Inc. SAGE Publications, Inc, Thousand Oaks, CA, pp 811–812
16. Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101
17. Drew S et al (2015) Implementation of secondary fracture prevention services after hip fracture: a qualitative study using extended normalization process theory. Implement Sci 10(1):57
18. ATKINSON R, Flint J (2003) Sampling, snowball: accessing hidden and hard-to-reach populations, The A-Z of Social Research. SAGE Publications, Ltd, London, England, pp 275–281
19. Ritchie J, Lewis J (eds) (2003) Qualitative research practice: a guide for social science students and researchers. Sage, London
20. NICE (2005) NICE Technology Appraisal 87: Bisphosphonates (alendronate, etidonate or risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in post menopausal women
21. NICE (2010) NICE technology appraisal guidelines 204: Denosumab for the prevention of osteoporotic fractures in postmenopausal women
22. Directorate, H.a.S.C. (2014) Indicators process guide. National Institute for Health and Care Excellence
23. Department of Health (2006) The musculoskeletal services framework
24. Papaioannou A et al (2007) Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 24(1):37–55
25. Boonen S et al (2012) Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis. J Bone Miner Res 27(7):1487–1493
26. Lee S, Glendenning P, Inderjeeth CA (2011) Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009. Osteoporos Int 22(3):741–753
27. Silverman SL et al (2015) Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study. Osteoporos Int 26(1):361–372
28. Clowes JA, Peel NFA, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89(3):1117–1123
29. Mitchell PJ (2013) Best practices in secondary fracture prevention: fracture liaison services. Curr Osteoporos Rep 11(1):52–60
30. Ganda K et al (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24(2):393–406
31. Eisman JA et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27(10):2039–2046
32. Baker S.E, Edwards R (2012) How many qualitative interviews is enough? Nat Centre Rese Methods